ESSA Pharma EPS - Earnings per Share 2015-2025 | EPIX

ESSA Pharma eps - earnings per share from 2015 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
ESSA Pharma Annual EPS
2024 $-0.64
2023 $-0.60
2022 $-0.80
2021 $-0.96
2020 $-1.04
2019 $-1.51
2018 $-2.55
2017 $-3.09
2016 $-9.80
2015 $-10.60
2014 $-2.40
ESSA Pharma Quarterly EPS
2025-03-31 $-0.14
2024-12-31 $-0.19
2024-09-30 $-0.14
2024-06-30 $-0.16
2024-03-31 $-0.20
2023-12-31 $-0.14
2023-09-30 $-0.12
2023-06-30 $-0.17
2023-03-31 $-0.16
2022-12-31 $-0.15
2022-09-30 $-0.14
2022-06-30 $-0.20
2022-03-31 $-0.25
2021-12-31 $-0.21
2021-09-30 $-0.19
2021-06-30 $-0.21
2021-03-31 $-0.36
2020-12-31 $-0.20
2020-09-30 $-0.13
2020-06-30 $-0.24
2020-03-31 $-0.45
2019-12-31 $-0.22
2019-09-30 $-0.02
2019-06-30 $-0.52
2019-03-31 $-0.54
2018-12-31 $-0.43
2018-09-30 $0.22
2018-06-30 $-0.50
2018-03-31 $-0.83
2017-12-31 $-1.44
2017-09-30 $-1.18
2017-06-30 $2.32
2017-03-31 $-5.23
2016-12-31 $1.00
2016-09-30 $-2.80
2016-06-30 $-2.60
2016-03-31 $-0.80
2015-12-31 $-3.60
2015-09-30 $0.80
2015-06-30 $-5.80
2015-03-31 $-4.00
2014-12-31 $-1.60
2014-09-30 $0.00
Sector Industry Market Cap Revenue
Medical MED-DRUGS $0.083B $0.000B
ESSA Pharma Inc. is a pharmaceutical company. The company focused on the development of small molecule drugs for the treatment of cancer, with focus on advanced prostate cancer. ESSA Pharma Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) JP $79.248B 30.48
Zoetis (ZTS) US $64.907B 24.22
Daiichi Sankyo, - (DSNKY) JP $46.828B 24.00
Takeda Pharmaceutical (TAK) JP $43.656B 8.91
BeOne Medicines - (ONC) KY $33.004B 0.00
Sandoz Group AG (SDZNY) CH $25.084B 0.00
Summit Therapeutics (SMMT) US $19.584B 0.00
Merck (MKKGY) DE $16.168B 11.85
Shionogi (SGIOY) JP $14.172B 14.20
Neurocrine Biosciences (NBIX) US $12.718B 37.94
United Therapeutics (UTHR) US $12.391B 10.72
Orion OYJ (ORINY) FI $11.482B 27.67
IPSEN (IPSEY) FR $10.802B 0.00
Stevanato Group S.p.A (STVN) IT $7.483B 45.76
Grifols, S.A (GRFS) ES $7.357B 0.00
Corcept Therapeutics (CORT) US $7.123B 59.44
Ionis Pharmaceuticals (IONS) US $6.851B 0.00
Madrigal Pharmaceuticals (MDGL) US $6.717B 0.00
Hikma Pharmaceuticals Plc (HKMPF) GB $5.853B 0.00
Ono Pharmaceutical (OPHLF) JP $5.214B 15.86
Soleno Therapeutics (SLNO) US $4.358B 0.00
Hypermarcas (HYPMY) BR $2.987B 19.65
Crinetics Pharmaceuticals (CRNX) US $2.677B 0.00
Catalyst Pharmaceuticals (CPRX) US $2.602B 9.12
AMNEAL PHARMACEUTICALS, INC (AMRX) US $2.451B 13.25
NewAmsterdam Pharma (NAMS) NL $2.449B 0.00
Centessa Pharmaceuticals (CNTA) GB $2.294B 0.00
Ocular Therapeutix (OCUL) US $1.845B 0.00
Endo (NDOI) US $1.800B 0.00
ARS Pharmaceuticals (SPRY) US $1.736B 0.00
BioCryst Pharmaceuticals (BCRX) US $1.703B 0.00
Evotec AG (EVO) DE $1.413B 0.00
Dyne Therapeutics (DYN) US $1.401B 0.00
Guardian Pharmacy Services (GRDN) US $1.323B 0.00
Aurinia Pharmaceuticals Inc (AUPH) CA $1.249B 18.13
Harrow (HROW) US $1.165B 0.00
Avadel Pharmaceuticals (AVDL) IE $1.017B 0.00
Ardelyx (ARDX) US $1.014B 0.00
Akebia Therapeutics (AKBA) US $0.968B 0.00
Collegium Pharmaceutical (COLL) US $0.959B 5.18
Enliven Therapeutics (ELVN) US $0.923B 0.00
ProKidney (PROK) US $0.811B 0.00
Xeris Biopharma Holdings (XERS) US $0.796B 0.00
Cronos Group (CRON) CA $0.764B 0.00
Amylyx Pharmaceuticals (AMLX) US $0.716B 0.00
KalVista Pharmaceuticals (KALV) US $0.681B 0.00
Zevra Therapeutics (ZVRA) US $0.607B 0.00
Relay Therapeutics (RLAY) US $0.603B 0.00
Xencor (XNCR) US $0.592B 0.00
Organogenesis (ORGO) US $0.586B 0.00
Tourmaline Bio (TRML) US $0.568B 0.00
Theravance Biopharma (TBPH) US $0.558B 0.00
USANA Health Sciences (USNA) US $0.547B 11.01
Elite Pharmaceuticals (ELTP) US $0.546B 0.00
Bioventus (BVS) US $0.536B 13.58
Oruka Therapeutics (ORKA) US $0.509B 0.00
Siga Technologies (SIGA) US $0.472B 9.87
Savara (SVRA) US $0.448B 0.00
Aquestive Therapeutics (AQST) US $0.381B 0.00
Rigel Pharmaceuticals (RIGL) US $0.376B 10.17
AleAnna (ANNA) US $0.339B 0.00
Nanobiotix S.A (NBTX) FR $0.325B 0.00
Altimmune (ALT) US $0.299B 0.00
Aldeyra Therapeutics (ALDX) US $0.299B 0.00
Esperion Therapeutics (ESPR) US $0.281B 0.00
Tonix Pharmaceuticals Holding (TNXP) US $0.277B 0.00
Nektar Therapeutics (NKTR) US $0.269B 0.00
Heron Therapeutics (HRTX) US $0.264B 0.00
Nature's Sunshine Products (NATR) US $0.259B 16.10
OmniAb (OABI) US $0.233B 0.00
Galectin Therapeutics (GALT) US $0.230B 0.00
Larimar Therapeutics (LRMR) US $0.222B 0.00
4D Molecular Therapeutics (FDMT) US $0.208B 0.00
MediWound (MDWD) IL $0.201B 0.00
China SXT Pharmaceuticals (SXTC) CN $0.181B 0.00
Lyell Immunopharma (LYEL) US $0.175B 0.00
Journey Medical (DERM) US $0.171B 0.00
Profound Medical (PROF) CA $0.167B 0.00
Aclaris Therapeutics (ACRS) US $0.166B 0.00
Liminatus Pharma (LIMN) US $0.163B 0.00
Lexeo Therapeutics (LXEO) US $0.157B 0.00
Korro Bio (KRRO) US $0.140B 0.00
Avita Medical (RCEL) US $0.140B 0.00
Ironwood Pharmaceuticals (IRWD) US $0.124B 0.00
Cardiol Therapeutics (CRDL) CA $0.123B 0.00
Protara Therapeutics (TARA) US $0.120B 0.00
Inhibikase Therapeutics (IKT) US $0.117B 0.00
Corbus Pharmaceuticals Holdings (CRBP) US $0.113B 0.00
Innate Pharma SA (IPHYF) FR $0.110B 0.00
Cassava Sciences (SAVA) US $0.101B 0.00
Achieve Life Sciences (ACHV) CA $0.091B 0.00
Fractyl Health (GUTS) US $0.090B 0.00
Champions Oncology (CSBR) US $0.087B 19.75
Metagenomi (MGX) US $0.086B 0.00
Surrozen (SRZN) US $0.086B 0.00
Avalo Therapeutics (AVTX) US $0.085B 0.00
VAXART, INC (VXRT) US $0.085B 0.00
Arch Biopartners (ACHFF) CA $0.081B 0.00
Nutriband (NTRB) US $0.080B 0.00
Vivani Medical (VANI) US $0.079B 0.00
PMV Pharmaceuticals (PMVP) US $0.074B 0.00
Pyxis Oncology (PYXS) US $0.069B 0.00
Inotiv (NOTV) US $0.069B 0.00
Assertio Holdings (ASRT) US $0.069B 0.00
Dominari Holdings (DOMH) US $0.067B 0.00
Wellgistics Health (WGRX) US $0.066B 0.00
Context Therapeutics (CNTX) US $0.065B 0.00
Rafael Holdings (RFL) US $0.059B 0.00
DURECT (DRRX) US $0.058B 0.00
Telomir Pharmaceuticals (TELO) US $0.056B 0.00
Unicycive Therapeutics (UNCY) US $0.055B 0.00
Verrica Pharmaceuticals (VRCA) US $0.052B 0.00
ElectroCore (ECOR) US $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) US $0.052B 38.33
Century Therapeutics (IPSC) US $0.047B 0.00
NRx Pharmaceuticals (NRXP) US $0.047B 0.00
Jupiter Neurosciences (JUNS) US $0.046B 0.00
Klotho Neurosciences (KLTO) US $0.044B 0.00
Prelude Therapeutics (PRLD) US $0.044B 0.00
Gain Therapeutics (GANX) US $0.044B 0.00
Acrivon Therapeutics (ACRV) US $0.040B 0.00
Mural Oncology (MURA) IE $0.039B 0.00
Enlivex Therapeutics (ENLV) IL $0.035B 0.00
PolyPid (PYPD) IL $0.034B 0.00
Karyopharm Therapeutics (KPTI) US $0.033B 0.00
Iterum Therapeutics (ITRM) IE $0.031B 0.00
Plus Therapeutics (PSTV) US $0.029B 0.00
FibroGen (FGEN) US $0.028B 0.00
SCYNEXIS (SCYX) US $0.027B 0.00
Tempest Therapeutics (TPST) US $0.027B 0.00
Cosmos Health (COSM) US $0.027B 0.00
Vivos Therapeutics (VVOS) US $0.026B 0.00
Scienture Holdings (SCNX) US $0.025B 0.00
Reviva Pharmaceuticals Holdings (RVPH) US $0.022B 0.00
Natural Alternatives (NAII) US $0.022B 0.00
Relmada Therapeutics (RLMD) US $0.021B 0.00
Lipocine (LPCN) US $0.017B 0.00
Incannex Healthcare (IXHL) AU $0.017B 0.00
BioLineRx (BLRX) IL $0.017B 0.00
CASI Pharmaceuticals (CASI) CN $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) US $0.016B 0.00
Mannatech (MTEX) US $0.016B 0.00
ProPhase Labs (PRPH) US $0.015B 0.00
Citius Pharmaceuticals (CTXR) US $0.015B 0.00
Carisma Therapeutics (CARM) US $0.013B 0.00
TherapeuticsMD (TXMD) US $0.013B 0.00
Ernexa Therapeutics (ERNA) US $0.013B 0.00
Phio Pharmaceuticals (PHIO) US $0.011B 0.00
BioVie (BIVI) US $0.011B 0.00
Ainos (AIMD) US $0.011B 0.00
TransCode Therapeutics (RNAZ) US $0.009B 0.00
Lyra Therapeutics (LYRA) US $0.009B 0.00
Addex Therapeutics (ADXN) CH $0.009B 0.00
Mangoceuticals (MGRX) US $0.009B 0.00
Talphera (TLPH) US $0.009B 0.00
Traws Pharma (TRAW) US $0.009B 0.00
Aptorum Group (APM) GB $0.008B 0.00
Biomerica (BMRA) US $0.008B 0.00
Kiora Pharmaceuticals (KPRX) US $0.008B 0.00
XTL Biopharmaceuticals (XTLB) IL $0.008B 0.00
Nuvilex (PMCB) US $0.007B 0.00
NLS Pharmaceutics (NLSP) CH $0.007B 0.00
VYNE Therapeutics (VYNE) US $0.006B 0.00
Xenetic Biosciences (XBIO) US $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) US $0.005B 0.00
InMed Pharmaceuticals (INM) CA $0.005B 0.00
Indaptus Therapeutics (INDP) US $0.005B 0.00
Alaunos Therapeutics (TCRT) US $0.005B 0.00
Clearmind Medicine (CMND) CA $0.004B 0.00
Quoin Pharmaceuticals (QNRX) US $0.004B 0.00
XORTX Therapeutics (XRTX) CA $0.004B 0.00
Qualigen Therapeutics (QLGN) US $0.004B 0.00
SHINECO (SISI) CN $0.003B 0.00
SciSparc (SPRC) IL $0.003B 0.00
Redhill Biopharma (RDHL) IL $0.003B 0.00
CERo Therapeutics Holdings (CERO) US $0.003B 0.00
PainReform (PRFX) IL $0.003B 0.00
Galmed Pharmaceuticals (GLMD) IL $0.003B 0.00
Heatwurx (PCSA) US $0.003B 0.00
Aditxt (ADTX) US $0.002B 0.00
Jaguar Animal Health (JAGX) US $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) US $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) US $0.002B 0.00
TNF Pharmaceuticals (TNFA) US $0.002B 0.00
Conduit Pharmaceuticals (CDT) US $0.001B 0.00
Salarius Pharmaceuticals (SLRX) US $0.001B 0.00
Universe Pharmaceuticals INC (UPC) CN $0.000B 0.00
Indivior (INDV) US $0.000B 11.35
4D Pharma (LBPS) GB $0.000B 0.00
MEI Pharma (MEIP) US $0.000B 0.00
Minerva Neurosciences (NERV) US $0.000B 2.28
Patheon (PTHN) NL $0.000B 0.00
RVL Pharmaceuticals (RVLP) US $0.000B 0.00
Silence Therapeutics (SLN) GB $0.000B 0.00